Washington DC-Baltimore Area
Medical Affairs Executive with over 25 years of progressive leadership experience across oncology, immuno-oncology, antibody-drug conjugates (ADCs), and targeted therapies within leading biopharmaceutical organizations. Proven track record leading enterprise medical strategy, building and developing high-performing field medical organizations, and driving successful launches across complex oncology portfolios. Currently leading oncology field medical teams supporting major growth drivers in gynecologic and breast malignancies, including launch readiness, strategic execution, and cross-functional collaboration for emerging ADC and immuno-oncology therapies. Experienced managing large, geographically dispersed medical teams within highly matrixed organizations while aligning field execution with enterprise objectives. Board certified in Oncology Pharmacy (BCOP), Pharmacotherapy (BCPS), and Clinical Research (ACRP-CP), with deep expertise in Medical Affairs leadership, MSL team development, payer and health systems engagement, biomarkers, companion diagnostics, evidence generation, alliance leadership, and medical strategy execution. Recognized for combining scientific credibility, strategic thinking, and operational discipline to strengthen stakeholder engagement, advance patient access, and support organizational growth during periods of rapid innovation and organizational transformation. CliftonStrengths Top 10: Achiever | Responsibility | Learner | Discipline | Relator | Analytical | Arranger | Intellection | Strategic | Focus Core Areas of Expertise: Medical Affairs Leadership | Oncology | Immuno-Oncology | Antibody Drug Conjugates (ADCs) | MSL Leadership | Health Systems | Payers | Market Access | Biomarkers | Companion Diagnostics | Targeted Therapies | Evidence Generation | Launch Strategy | Cross-Functional Leadership Email: [email protected]
Lead strategy and execution for the gynecologic cancers field medical affairs team, including managing HQ-based strategy roles, field-based management, and regional medical science liaisons
Payers, Pathways, Health Systems